# OnCo record vedolizumab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/vedolizumab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "vedolizumab" ;
  schema:name "Vedolizumab"@en ;
  schema:description "Vedolizumab is a gut-targeted anti-inflammatory drip for ulcerative colitis and Crohn's disease, used when colitis caused by checkpoint immunotherapy does not settle with steroids and infliximab."@en ;
  schema:url <https://onco.cc/drugs/vedolizumab/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Vedolizumab> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e94621c-1a95-4af9-98d1-52b9e6f1949c>, <https://doi.org/10.1136/jitc-2021-002435> ;
  onco:status "approved" ;
  onco:tag "supportive", "generic", "supportive-care-gaps-2026-11" ;
  onco:modality "Monoclonal antibody (gut-selective integrin receptor antagonist)" ;
  schema:alternateName "Entyvio" ;
  onco:approval "US 2014: Moderately to severely active ulcerative colitis and Crohn's disease in adults" ;
  onco:related <https://onco.cc/drugs/infliximab/> ;
  onco:terms <https://onco.cc/terms/immune-colitis/>, <https://onco.cc/terms/irae/> .